Faculty of Pharmacy, Universitas Mahasaraswati Denpasar, Bali, Indonesia.
Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Pharmacogenomics. 2024;25(8-9):357-365. doi: 10.1080/14622416.2024.2375190. Epub 2024 Jul 29.
Hypertension is a prevalent health concern in Indonesia, with a high percentage of patients unresponsive to ACE inhibitor treatment. This multicenter case-control study investigated the correlation between ACE I/D and captopril effectiveness in Indonesian hypertensive patients. Hypertensive patients were divided into control (n = 69) and case (n = 73) groups. was identified using PCR and electrophoresis. No significant differences in genotype frequencies or allele distribution were observed. The difference of blood pressure reduction among the three genotypes also lacked statistical significance. is not significantly associated with blood pressure reduction following captopril therapy in Indonesian hypertensive patients. These results underscore the limited predictive utility of in managing hypertension with captopril.
高血压是印度尼西亚普遍存在的健康问题,很大比例的患者对 ACE 抑制剂治疗无反应。这项多中心病例对照研究调查了 ACE I/D 与卡托普利在印度尼西亚高血压患者中的有效性之间的相关性。高血压患者分为对照组(n=69)和病例组(n=73)。使用 PCR 和电泳法鉴定基因型。基因型频率或等位基因分布无显著差异。三种基因型之间的血压降低差异也没有统计学意义。在印度尼西亚高血压患者中,ACE I/D 与卡托普利治疗后的血压降低无显著相关性。这些结果突出表明,ACE I/D 在使用卡托普利治疗高血压方面的预测作用有限。